| Order number | Description | Quantity | Delivery time | CE |
|---|---|---|---|---|
| PB CCWLP-10 | Weak Lupus Positive Control | 25x1 ml | 7-10 days | x |
Weak Lupus Positive ControlCRYOcheck Weak Lupus Positive Control is prepared from human source plasma and is recommended for use as a positive control in assays for lupus anticoagulant. An association between circulating anticoagulants and systemic lupus erythematosus (SLE) was first described in 19521. In 1972 the term “lupus anticoagulant” (LA) was used to describe these non-specific, circulating inhibitors2. The designation LA is still used today although it is now evident the majority of these patients do not suffer from SLE3. The presence of LA has been increasingly associated with a variety of disorders such as unexplained thrombosis and recurrent fetal loss4,5. LA are immunoglobulins, usually of the IgG, IgM or IgA classes,
|
Additional Documentation
|
Login